Developing Clinical Trial Outsourcing Strategies that Scale As Biotechs Do

Small- to mid-size clinical trial sponsors are increasingly important drivers of innovation in the pharma and biotech industry. Given their more limited R&D resources and in-house expertise, it is especially important for them to leverage outsourcing models that enable and accelerate clinical development quickly and cost-effectively. This panel will cover best practices small-to-mid-size organizations can employ to ensure flexibility, their ability to scale and increase the value of outsourcing partnerships over time. 

Moderator: Taren Grom



  • Amir Malka, President & Co-Founder, Bioforum the Data Masters

  • Guy Goldberg, Chief Business Officer, RedHill Biopharma

  • Kanchan Relwani, VP and Head of Medical Affairs, Alkermes, 2020